AMA, Zipnosis & more — 5 medical societies, health IT companies lobbying on telehealth, PDMPs

Medical societies and health IT companies ramped up their lobbying efforts on telehealth and prescription drug monitoring programs during the first quarter of 2018, according to a Politico analysis of lobbying disclosures.

Advertisement

Here are notes on five healthcare organizations and their first-quarter lobbying efforts.

1. The American Medical Association spent roughly $6.6 million on lobbying efforts during the first quarter, including on issues related to EHR-PDMP interoperability, e-prescribing and telemedicine.

2. The American Association of Medical Colleges disclosed roughly $1.14 million on lobbying activities, including “enhancing usability of PDMPs.”

3. The American College of Physician Services — a division within the American College of Physicians — spent roughly $250,000 on lobbying efforts, including advocating for a more comprehensive PDMP system.

4. Appriss, which provides software for many state PDMPs, paid Akin Gump Strauss Hauer & Feld roughly $50,000, including for activities related to PDMP programs and legislation.

5. Zipnosis, a virtual care company, paid Duetto roughly $10,000, including for activities related to “support for telemedicine via Software as a Service.”

More articles on telehealth:
AHA opposes ‘unexpected,’ ‘significant’ funding cuts in FCC’s rural telehealth program
Temple Health telehealth spinout HGE Health expands lung care services
Zipnosis adds post-surgical care services to telehealth platform

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Telehealth

Advertisement

Comments are closed.